BUE Equity Snapshot

NVS Weekly Equity Report

Novartis AG

Latest Close 57,275 ARS 12 Jun 2026
1W Return 1.7% latest completed week
4W Return 4.1% short-term follow-through
12W Return 6.8% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
Company Brief

What the company does

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of …

Snapshot

What the weekly tape is saying

NVS closed the latest completed week at 57,275 ARS. The 4-week return is 4.1% and the 12-week return is 6.8%. Trend Signal is active, Market Dynamics is -0.61. Setup signature: Balanced read with a 47/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 3.7%
Volume 0.1x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 100 Persistence of active Trend Signal over the last year and current streak.
Momentum 65 Blend of 4-week and 12-week follow-through.
Dynamics 41 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 6 Participation compared with the 13-week volume baseline.
Risk Control 69 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
55,250 ARS
Vs Trend Line
3.7%
Fair Value
35,794 ARS
Vs Fair Value
60.0%
52W High
63,199 ARS
52W Low
33,649 ARS
Drawdown
-9.4%
Range Position
80.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.7%
4W 4.1%
12W 6.8%
26W 14.6%
52W 60.9%

Trend read

Active Streak
63 weeks
52W Active Weeks
52
52W Active Breadth
100.0%
Sector Scope
AR Healthcare
Sector Rank
4 of 20
Sector Percentile
84.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.61
4W MD Change
22.8%
Relative Strength
-13.18
4W RS Change
-403.9%
Expectation
Positive
Probability
57.97%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
260
13W Average
1.8K
52W Average
1.4K
Vs 13W
0.1x
Vs 52W
0.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.7%
52W Volatility
3.6%
Upside Weeks
32
Downside Weeks
20
Downside Breadth
38.5%
Avg Gain / Loss
3.2% / -2.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
51900.1B

Opportunity signals

  • Trend Signal is active with a 63-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 57,275 ARS 1.7% 55,250 ARS 35,794 ARS -0.61 -13.18 260 On
5 Jun 2026 56,325 ARS 0.9% 54,973 ARS 35,508 ARS -0.56 -7.17 1.9K On
29 May 2026 55,850 ARS -1.1% 54,651 ARS 35,226 ARS -0.60 -10.17 1.6K On
22 May 2026 56,475 ARS 2.6% 54,341 ARS 34,945 ARS -0.64 1.29 7.5K On
15 May 2026 55,025 ARS 1.1% 54,159 ARS 34,660 ARS -0.79 4.34 5.0K On
8 May 2026 54,400 ARS -2.0% 54,025 ARS 34,385 ARS -0.85 1.53 1.1K On
1 May 2026 55,500 ARS 2.1% 53,834 ARS 34,112 ARS -0.83 1.73 443 On
24 Apr 2026 54,375 ARS -2.2% 53,668 ARS 33,832 ARS -0.72 -0.25 1.3K On
17 Apr 2026 55,600 ARS -1.9% 53,372 ARS 33,556 ARS -0.76 0.69 1.8K On
10 Apr 2026 56,700 ARS -1.8% 53,120 ARS 33,272 ARS -0.82 -0.64 550 On
3 Apr 2026 57,750 ARS 5.4% 52,764 ARS 32,970 ARS -0.63 1.47 1.3K On
27 Mar 2026 54,800 ARS 2.1% 52,335 ARS 32,661 ARS -0.24 3.63 167 On
20 Mar 2026 53,650 ARS -5.1% 51,932 ARS 32,368 ARS 0.47 4.45 306 On
13 Mar 2026 56,525 ARS -4.6% 51,557 ARS 32,075 ARS 1.10 14.05 623 On